Tarsons Products Ltd Stock Price Today (NSE: TARSONS)

Tarsons Products Ltd

278.11+39.38 (+16.50%)
Market Closed

Fundamental Score

...

Tarsons Products Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Tarsons Products Ltd share price today is 278.11, up +16.50% on NSE/BSE as of 17 June 2026. Tarsons Products Ltd (TARSONS) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of 1.22K (Cr). The 52-week high for TARSONS share price is 402.85 and the 52-week low is 164.45. At a P/E ratio of 59.58x, TARSONS is currently trading above its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 4.75% and a debt-to-equity ratio of 0.63.

Tarsons Products Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
278.11
Low
198.24
Volume
2.0L
Change
-1.70%

Tarsons Products Ltd share price chart: -1.70% return over the past month. 52-week high ₹402.85, 52-week low ₹164.45.

Tarsons Products Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
208.01209.60205.61207.5454.08K (Cr)
207.99214.30206.10208.8859.57K (Cr)
215.10217.56206.82209.463.23L (Cr)
214.98214.98214.98214.980.00 (Cr)
220.68222.99213.00214.9871.06K (Cr)
214.00225.00210.98220.683.90L (Cr)
217.70257.50211.35214.7018.97L (Cr)
210.79221.00209.06218.712.18L (Cr)
216.48216.48210.00211.0329.20K (Cr)
211.38215.98209.42212.7132.62K (Cr)

Tarsons Products Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
207.99214.30205.61207.54-0.22%
219.92257.50198.24209.46-4.76%
168.60222.90168.60219.92+30.44%
186.00207.85164.45166.46-10.51%
196.00234.67184.30190.80-2.65%
235.17237.00192.30194.10-17.46%
225.99243.80213.40233.30+3.23%
290.00292.00198.00225.45-22.26%
305.00309.95286.00289.05-5.23%
313.40330.00301.80305.15-2.63%
362.00382.10308.60311.80-13.87%
395.00402.85357.10365.70-7.42%

AI Research Briefing

Powered by Gemini · 2026-04-09

Small-cap hope trade with brutal profitability headwinds; avoid until numbers prove the story.

Research Confidence
5.0/10Moderate
MICRO-CAP DARK HORSEBreakdown (1M: -20.37%, 3M: -27.62%, 6M: -39.97%)Expensive (P/E: 59.58x vs Industry P/E: 47.87x)

WHAT'S HAPPENING NOW (last 2-4 weeks)

Tarsons Products closed its trading window on April 1, 2026, ahead of the FY26 audited results announcement. On March 30, 2026, the stock hit an all-time low of

CORE STORY (THE REAL GAME)

Why Now
  • Q3 FY26 showed QoQ revenue growth of 5.43%
  • Operating profit increased QoQ by 9.91%
  • Net profit jumped QoQ by 51.81%
Potential Catalysts
  • Stronger-than-expected earnings
  • Significant order wins
  • Successful integration of Nerbe acquisition
Key Risks
  • Small-cap: liquidity risk
  • High P/E ratio compared to industry average
  • Negative operating profit growth over the past five years
Institutional Activity

FII decreased their stake by 3.32%

Macro Context

Medical devices sector in India is projected to grow, supported by infrastructure expansion and government initiatives

Cash Flow Quality

No free cash flow data available

3–6 Month Outlook

Company aims to capitalize on the growing Indian plastic labware industry. Success depends on capacity expansion, product development, and navigating competitive pressures.

Primary Thesis Risk

Inability to translate revenue growth into sustained profitability.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

4.75%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

6.91%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Tarsons Products Ltd Valuation Check

Poor

Price to Earnings (P/E)

59.58x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

47.87x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

47.31%

% shares held by company founders/management

Average

FII Holding

5.82%

% shares held by foreign institutional investors

Poor

DII Holding

0.08%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-67.74%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

3.10%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

0.63x

Total debt ÷ equity. Below 0.5 = financially healthy

Average

Interest Coverage Ratio

2.57x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Tarsons Products Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of TARSONS across key market metrics for learning purposes.

Positive Indicators

1 factors identified

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

6 factors identified

Below-Average Return on Equity (4.75%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (6.91%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 59.58x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-67.74%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Institutional Interest (FII+DII: 5.90%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Tarsons Products Ltd vs Medical Equipment & Supplies Peers

Peer Comparison - Medical Equipment & Supplies

Compare Tarsons Products Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
13.8/100
278
₹1224.98
59.6
Average
4.75%
Poor
6.91%
Poor
0.6
Good
0.00%
60.7/100
1455
₹19506.20
53.9
Average
15.77%
Good
20.08%
Excellent
0.1
Excellent
28.38%
Excellent
19.44%
Excellent
0.18%
31.7/100
35
₹3162.93
157.5
Average
0.70%
Poor
1.08%
Poor
0.1
Excellent
0.01%
68.7/100
204
₹1488.44
57.8
Average
21.88%
Excellent
19.20%
Good
0.0
Excellent
57.51%
Excellent
9.81%
Good
0.00%
42.1/100
518
₹1363.11
50.1
Average
30.08%
Excellent
31.14%
Excellent
0.6
Good
0.00%
60.3/100
173
₹633.93
25.8
Average
36.78%
Excellent
31.12%
Excellent
0.5
Good
90.06%
Excellent
61.82%
Excellent
0.00%
68.5/100
396
₹521.17
26.2
Average
18.74%
Good
25.25%
Excellent
0.0
Excellent
29.49%
Excellent
22.80%
Excellent
0.23%
61.2/100
386
₹354.57
34.2
Average
13.58%
Average
16.35%
Good
0.4
Excellent
74.11%
Excellent
13.69%
Good
0.00%
47.7/100
191
₹294.37
32.7
Average
13.56%
Average
18.45%
Good
0.0
Excellent
0.00%
Nureca Ltd...
NURECA543264
36/100
276
₹292.61
71.2
Average
-1.12%
Poor
-0.90%
Poor
0.0
Excellent
1.98%
Average
0.00%
29.6/100
83
₹189.41
15.4
Average
14.36%
Average
16.60%
Good
0.6
Good
0.51%

Tarsons Products Ltd PE Ratio History

Historical price-to-earnings ratio for TARSONS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20255.60₹233.3041.7x
FY 20248.01₹403.6550.4x
FY 202315.17₹527.3034.8x
FY 202219.46₹694.4535.7x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Tarsons Products Ltd Quarterly Performance

Latest quarterly metrics for TARSONS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

3.10%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-67.74%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Tarsons Products Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for TARSONS — calculated from daily price history

39RSI 14
Neutral — RSI 39

Momentum is balanced — neither overbought nor oversold.

SMA 50
204
▲ Price above SMA 50 — Short-term bullish
SMA 200
245
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
164K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Tarsons Products Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Tarsons Products Ltd (TARSONS) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Tarsons Products Ltd

About TARSONS (Tarsons Products Ltd)

Tarsons Products Ltd is a prominent Indian manufacturer specializing in the creation and distribution of high-quality laboratory plasticware. They offer a diverse catalog of produc...ts critical to scientific research and development, catering to a broad spectrum of applications within laboratories. The company's portfolio encompasses an array of essential items, carefully designed for precise and reliable use in various scientific procedures. From basic storage solutions to advanced consumables, Tarsons aims to provide researchers with the tools necessary to conduct experiments efficiently and accurately. Their commitment to quality materials and innovative designs underscores their dedication to supporting the scientific community. Tarsons' product line demonstrates a thorough understanding of the diverse needs of modern laboratories. Their offerings range from specialized containers for cell culture and cryopreservation to essential components for liquid handling and filtration. The meticulous design of their products considers factors like chemical compatibility, temperature resistance, and ease of use. Furthermore, the company recognizes the growing importance of genomics and PCR-based research, offering a comprehensive range of consumables optimized for these applications. By providing a wide selection of both disposable and reusable items, Tarsons strives to meet the varied requirements of different research settings, from academic institutions to industrial laboratories. Through a commitment to quality and a comprehensive product range, Tarsons Products Ltd plays a vital role in supporting the advancement of scientific discovery. Their products are integral to a multitude of research processes, offering scientists the tools they require to conduct experiments with precision and confidence. The company's unwavering focus on innovation and customer satisfaction solidifies its position as a trusted supplier of laboratory plasticware. Their reach extends beyond domestic markets, establishing Tarsons as a significant contributor to the global scientific community.

Company Details

Symbol:TARSONS
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies

Key Leadership

Mr. Sanjive Sehgal
Chairman, CEO & MD
Mr. Santosh Kumar Agarwal
CFO, Company Secretary & Compliance Officer
Mr. Aryan Sehgal
Whole-time Director

TARSONS Share Price: Frequently Asked Questions

What is the current share price of Tarsons Products Ltd?

Tarsons Products Ltd (TARSONS) trades at ₹278.11 on NSE and BSE. Market cap ₹1.22K (Cr). Educational data only.

What is the P/E ratio of Tarsons Products Ltd?

Tarsons Products Ltd has a P/E of 59.58x vs industry average 47.87x.

What is the Bull Run score for Tarsons Products Ltd?

Tarsons Products Ltd has a Bull Run score of 13.8/100 based on 25+ financial parameters.

Does Tarsons Products Ltd pay dividends?

Tarsons Products Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Tarsons Products Ltd?

Tarsons Products Ltd has ROE of 4.75%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Tarsons Products Ltd?

Tarsons Products Ltd has debt-to-equity of 0.63.

Is Tarsons Products Ltd a good investment?

Bull Run gives Tarsons Products Ltd a score of 13.8/100. This is not investment advice — consult a SEBI-registered advisor.